Table 2.

Prevalence and distribution of TERT mutations in cancer genomes. The prevalence of TERT mutations in given as percentage and as total number of cases

Cancer type	Our study			Prevalence of mutations in published literatures
	Prevalence of mutations	c.1-124C>T (C228T)	c.1-146 C>T (C250T)
Urinary bladder	31/47 (66.0%)	24/31 (77.4%)	7/31 (22.6%)	29–100% [3, 6, 7, 35–38, 51]
Pancreatobiliary	19/127 (15.0%)	16/19 (84.2%)	3/19 (15.8%)	0–7% [5, 9, 42, 52]
Liver	22/41 (53.7%)	19/22 (86.4%)	3/22 (13.6%)	29–65% [35, 39, 40]
Melanoma	12/90 (13.2%)	5/12 (41.7%)	7/12 (58.3%)	60–100% [4, 15, 34]